IDEX beats Q3 estimates, with organic sales rising, as it focuses on execution amid uncertain macro conditions.
SoFi expands in Charlotte, posts strong Q3 results, and raises guidance amid mixed outlook for Payments and FinTech sector.
Incyte advances multiple early-phase cancer trials with potential therapeutic breakthroughs, highlighting their strategic focus on oncology and rare diseases.
IDEX beats Q3 estimates, with organic sales rising, as it focuses on execution amid uncertain macro conditions.
SoFi expands in Charlotte, posts strong Q3 results, and raises guidance amid mixed outlook for Payments and FinTech sector.
Incyte advances multiple early-phase cancer trials with potential therapeutic breakthroughs, highlighting their strategic focus on oncology and rare diseases.